Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Nat Med. 2013 Mar;19(3):364-7. doi: 10.1038/nm.3047. Epub 2013 Feb 10.
Widespread antibiotic resistance among important bacterial pathogens such as Staphylococcus aureus calls for alternative routes of drug development. Interfering with crucial virulence determinants is considered a promising new approach to control bacterial infection. Phenol-soluble modulins (PSMs) are peptide toxins with multiple key roles in pathogenesis and have a major impact on the ability of highly virulent S. aureus to cause disease. However, targeting PSMs for therapeutic intervention is hampered by their multitude and diversity. Here we report that an ATP-binding cassette transporter with previously unknown function is responsible for the export of all PSMs, thus representing a single target for complete obstruction of PSM production. The transporter had a strong effect on virulence phenotypes, such as neutrophil lysis, and the extent of its effect on the development of S. aureus infection was similar to that of the sum of all PSMs. Notably, the transporter was essential for bacterial growth. Furthermore, it contributed to producer immunity toward secreted PSMs and defense against PSM-mediated bacterial interference. Our study reveals a noncanonical, dedicated secretion mechanism for an important class of toxins and identifies this mechanism as a comprehensive potential target for the development of drugs to efficiently inhibit the growth and virulence of pathogenic staphylococci.
广泛存在于金黄色葡萄球菌等重要细菌病原体中的抗生素耐药性,需要寻找新的药物研发途径。干扰关键毒力决定因素被认为是控制细菌感染的一种有前途的新方法。酚可溶性调节素(PSMs)是具有多种关键致病作用的肽毒素,对高毒力金黄色葡萄球菌引起疾病的能力有重大影响。然而,由于 PSMs 的多样性和数量众多,针对 PSMs 进行治疗干预受到阻碍。在这里,我们报告称,一种具有未知功能的 ATP 结合盒转运蛋白负责所有 PSMs 的输出,因此代表了完全阻断 PSM 产生的单一靶标。该转运蛋白对毒力表型(如中性粒细胞溶解)有很强的影响,其对金黄色葡萄球菌感染发展的影响程度与所有 PSMs 的总和相似。值得注意的是,该转运蛋白对细菌生长是必需的。此外,它有助于细菌对分泌的 PSMs 的产生免疫和防御 PSM 介导的细菌干扰。我们的研究揭示了一类重要毒素的非典型、专用分泌机制,并将该机制确定为开发药物的综合潜在靶点,以有效抑制致病性葡萄球菌的生长和毒力。